Abstract Genetic manipulation is widely used to research the central nervous system (CNS). The manipulation of molecular expression in a small number of neurons permits the detailed investigation of the role of specific molecules on the function and morphology of the neurons. Electroporation is a broadly used technique for gene transfer in the CNS. However, the targeting of gene transfer using electroporation in postnatal animals was restricted to the cortex, hippocampus, or the region facing the ventricle in previous reports. Electroporation targeting of deep brain structures, such as the thalamus, has been difficult. We introduce a novel electroporation technique that enables gene transfer to a physiologically identified deep brain region using a glass pipette. We recorded neural activity in young-adult mice to identify the location of the lateral geniculate nucleus (LGN) of the thalamus, using a glass pipette electrode containing the plasmid DNA encoding enhanced green fluorescent protein (EGFP). The location of the LGN was confirmed by monitoring visual responses, and the plasmid solution was pressure-injected into the recording site. Voltage pulses were delivered through the glass pipette electrode. Several EGFP-labeled somata and dendrites were observed in the LGN after a few weeks, and labeled axons were found in the visual cortex. The EGFP-expressing structures were observed in detail sufficient to reconstruct their morphology in three dimensions. We further confirmed the applicability of this technique in cats. This method should be useful for the transfer of various genes into cells in physiologically identified brain regions in rodents and gyrencephalic mammals.
Introduction
The elucidation of neural circuitry and its function is a major interest in central nervous system (CNS) research. Genetic manipulation of cellular function is commonly used to elucidate the molecular mechanisms of brain function (Huang and Zeng 2013) . The manipulation of molecular expression in a small number of neurons in specified brain regions may be used to estimate the role of the molecules on the function and morphology of individual neurons in detail. Adaptation of this technique to the analysis of neural circuitry in gyrencephalic mammals would be invaluable. However, the present methods of gene transfer are not sufficient for this purpose because each method has restrictions regarding the species and age of animals, brain regions, and the size of the transgene (Washbourne and McAllister 2002; Karra and Dahm 2010) . For example, the generation of transgenic animals is a laborious, time-consuming, and costly process, and it is difficult to adapt this technique to gyrencephalic mammals. The use of viral vectors is limited by the size of the transgene and requires the manufacture of a virus; in addition, it is difficult to transfect a small number of cells. Electroporation of DNA has many advantages, including a nonpathogenic nature, the ability to transfer large transgenes, and rapid gene expression (De Vry et al. 2010a) . However, electroporation is usually used in utero to target the cells facing the ventricle (Tabata and Nakajima 2001) . In vivo postnatal electroporation is reported in several studies in which DNA is injected into the ventricle or other brain regions of interest, and electric pulses are given across the head or through coarse electrodes set close to the injection site (mouse: Boutin et al. 2008; Chesler et al. 2008; Barnabé-Heider et al. 2008; Mizuno et al. 2010; De Vry et al. 2010b , rat: Kondoh et al. 2000 Akaneya et al. 2005; Molotkov et al. 2010 , ferret: Borrell 2010 . Singlecell electroporation is used in postnatal animals, but it requires highly demanding techniques, such as patch-clamp recording, juxtacellular recording, or two-photon microscopy for in vivo imaging (Kitamura et al. 2008; Judkewitz et al. 2009; Cohen et al. 2013; Oyama et al. 2013 ). These methods of in vivo postnatal electroporation can target neurons only in restricted regions, such as the cortex or hippocampus.
We introduce a novel electroporation method that can target physiologically identified nuclei of the deep brain in postnatal animals. This method requires only a simple setup and conventional electrophysiological extracellular recording, and it enables the expression of fluorescent proteins in a few neurons at levels sufficient to examine neuronal morphology in detail. Furthermore, this method is applicable in rodents and gyrencephalic mammals, such as cats.
Materials and methods

Animals
C57BL/6 J mice at postnatal days (P) 27-405 and cats at P34-38 were used in this study. The mice were obtained from Japan SLC, Inc. (Shizuoka, Japan) or bred in the Tottori University Research Center for Bioscience and Technology. The cats were born in the breeding colony of the Tottori University Research Center for Bioscience and Technology. The animal care and use committee (permission number: 13-Y-15) and the safety committee for recombinant DNA experiment (permission number: 25-015) of Tottori University approved all experimental procedures.
Plasmid solution
Plasmid DNA driving enhanced green fluorescent protein (EGFP) expression under the cytomegalovirus enhancer and the chicken b-actin promoter, pCAG-EGFP, was purified using a Qiagen Plasmid Midi Kit (diluted in endotoxin-free TE buffer). The plasmid solution was diluted to 0.2-2.0 lg/ll with saline containing the anterograde neuronal tracer mini-Ruby (molecular probes). Trans-1, 2-cyclohexanediol (TCHD, Sigma) in Dulbecco's phosphate-buffered saline (DPBS) was added to the plasmid solution of 1.6 % (w/v) in certain instances. The solution was used for electrophysiological recordings and electroporation.
Preparation of glass pipettes
Micropipettes (3-000-203-G/X, Drummond) for a recordable auto-injector, Recording Nanoject II (Drummond), with an inner tip diameter of 15-20 lm were made on a micropipette puller (P-87, Sutter Instruments). Micropipettes filled with Ringer's solution were attached to the auto-injector, and a few microliters of the plasmid solution were sucked in from the tip.
In vivo postnatal electroporation Animals were anesthetized with 2.0-5.0 % isoflurane (2.0-3.0 % for mouse, 2.0-5.0 % for cat; Escaine, Mylan) in a 1:1 mixture of N 2 O:O 2 . The animals were fixed on a stereotaxic apparatus (Narishige). Rectal temperature during surgery was monitored and maintained at 37.0°C using a heating pad. The scalp was cut, and small segments of the skull above the target region for electroporation were removed for insertion of the glass pipette. The present study targeted the lateral geniculate nucleus (LGN) of the thalamus. LGN neurons show increased activity in response to the photic stimulation given to eyes. Gray triangles represent the start time of the photic stimulation for approximately 1 s. c, d A EGFPexpressing neuron was found in the vicinity of the neurons labeled with the red tracer, mini-Ruby, in the LGN. The contour of the LGN (dashed line) was identified using DAPI counterstaining. The region in the white rectangle is shown at higher magnification in e. scale bar 100 lm. e Enlarged view of EGFP-expressing soma and dendrites. Scale bar 50 lm. f Reconstruction of the EGFP-expressing LGN neuron in e (black, soma; blue, dendrite; red, axon). Scale bar 50 lm. g EGFP-expressing axons are observed in the visual cortex of the same animal in c-e. The region in the white rectangle is shown at higher magnification in h, i. A tungsten electrode (FHC) was positioned above the LGN stereotaxically (2.0-2.5 mm posterior to bregma and 2.0-2.5 mm to midline in mice; 7.5-8.0 mm anterior to ear bar and 3.7-4.9 mm to midline in cats), and multi-neuronal activities were recorded extracellularly (amplifier; Model 1800, A-M Systems; DAM 80, WPI: oscilloscope; VC-11, Nihon Kohden). The depth of the LGN was verified by the monitoring of the visual response to photic stimuli aurally (Model 3300, A-M systems; AM 10, Astro-Med).
The tungsten electrode was replaced with a glass pipette containing the plasmid solution attached to the recordable auto-injector. The location of the LGN was confirmed using the recording of neuronal activities through the pipette, and the wires for recording were replaced with the wires providing electric pulses (Fig. 1a) . The pipette was connected to the negative terminal, and the scalp was connected to the positive terminal of a stimulator (SEN-7203, Nihon Kohden) through an isolator (SS-104 J, Nihon Kohden). The plasmid solution was injected to the LGN using pressure (50.6 nl at 23 nl/sec, 3-5 times). The body of auto-injector was disconnected from its controller immediately after the injection, and electric pulses were delivered through the pipette. We applied five square pulses of 50-ms duration and 50-200 V amplitude at a frequency of 1 Hz. We performed electroporation at several sites in each animal.
The exposed cortex was covered with a gelatin sponge (Spongel, Yamanouchi) and dental cement (ADFA, Shofu) after electroporation. The surgical field was sterilized with povidone-iodine (Isodine, Meiji) diluted in Ringer's solution, and the scalp was sutured closed. A local anesthetic (Xylocaine Jelly, AstraZeneca) and antibiotic ointment (Gentacin Ointment, Schering-Plough) were applied to incisions. The animals were given an antimicrobial agent (enrofloxacin 5 mg/kg, Baytril, Bayer) daily after surgery.
Tissue preparation and staining
The animals were euthanized with an overdose of isoflurane after a survival period of 2-31 days and perfused transcardially with cold Ringer's solution followed by 4 % paraformaldehyde (PFA) in 0.1 M phosphate buffer (PB). The brain was removed and postfixed overnight in fixative containing 20 % sucrose. Mouse brain blocks were embedded in albumin-gelatin embedding medium (30 % egg albumin, 3 % gelatin, and 1 % glutaraldehyde in DW). Cat brain blocks were embedded in egg yolk. The brain blocks were stored at -80°C.
The brain blocks were cut on a freezing microtome in the coronal plane (50 lm thickness). All sections were collected in phosphate-buffered saline (PBS, pH 7.4), and some sections were transferred to a DAPI staining solution containing 0.01 % DAPI in PBS. Sections of EGFPexpressing structures were observed under a microscope, and selected sections were stained immunohistochemically to enhance EGFP signals. The sections were incubated in a solution of 3 % hydrogen peroxide in PBS for 20 min and washed in PBS. The sections were incubated in a blocking solution containing 5 % normal donkey serum (NDS; Jackson ImmunoResearch) and 1 % Triton X-100 in PBS for 1 h at room temperature. The sections were washed in PBS and transferred to a primary antibody solution containing anti-GFP monoclonal antibody (1:1000, rat, nacalai tesque), 3 % NDS and 1 % Triton X-100 in PBS overnight at 4°C. The sections were washed in PBS and transferred to a secondary antibody solution containing Alexa Fluor 488-conjugated anti-rat antibody (1:500, donkey, molecular probes), 3 % NDS, 0.5 % bovine serum albumin (BSA; Sigma) and 1 % Triton X-100 in PBS for 4 h at room temperature or overnight at 4°C. The sections were washed in PBS and incubated in a DAPI staining solution for 15 min. The stained sections were mounted on slides with 0.1 % gelatin in PBS and coverslipped with mounting agent (Fluoromount/Plus, Diagnostic BioSystems).
Image acquisition and three-dimensional reconstruction EGFP-labeled neurons were observed and captured with fluorescence microscopy (Nikon ECLIPSE E800; KEY-ENCE, BZ9000). We obtained stacks of high-resolution images (609 objective, 1 lm depth step) at multiple sites over the full extent of EGFP-expressing structures in each section for the three-dimensional reconstruction of neurons. The stacks for multiple sites were stitched to make a single stack using software (Fiji's stitching plug-in) (Preibisch et al. 2009; Schindelin et al. 2012) . EGFP-labeled structures (somata, dendrites, and cortical axon arbors) were reconstructed from serial sections in three dimensions on a computer using Neurolucida software (MicroBrightField). The distance along section thickness was corrected for tissue shrinkage.
Results
The transfer of genes to the deep brain nuclei requires the physiological identification of the target nuclei. We attempted to identify the target region by recording neural activity using a micropipette filled with plasmid solution, injecting the plasmid solution to the site, and performing electroporation using electric pulses through the same pipette. We targeted the LGN of the thalamus, which relays visual information from the retina to the visual cortex. We first determined the location of the LGN by recording multi-neuronal activities through a glass pipette (Fig. 1a) . After confirming the visual responses elicited by photic stimulations given to the eyes (Fig. 1b) , we reconfigured the electric circuits for electroporation (Fig. 1a) . A small amount of the plasmid solution containing pCAG-EGFP was injected together with a neuronal tracer, mini-Ruby which helps to find the injection site location. Electric pulses of 50-ms duration were given through the pipette at 1 Hz for 5 s immediately after the injection. The entire surgery was generally performed in 1-2 h.
An example of an injection site is shown in Fig. 1c, d . The electroporation was performed on P29 in this case, and the survival period was 2 weeks. We found an EGFPexpressing neuron in the LGN of an unprocessed section and processed the section for fluorescent immunostaining to visualize neuronal fine structures. The EGFP-expressing neuron was observed in the vicinity of the neurons labeled with mini-Ruby. The soma, dendrites, and an axon were observed clearly, which permitted the reconstruction of the entire cell morphology (Fig. 1e, f) . The relay neurons in the LGN project their axons to the primary visual cortex. We found EGFP-expressing axonal arbors in the primary visual cortex (Fig. 1g) . The labeled axons were arborized mainly in layers II/III and layer IV as reported previously (Fig. 1h, i) (Antonini et al. 1999 ). The geniculocortical axons were labeled well in the cortex, and fine structures, such as axonal boutons and filopodia-like structures at the terminal, were observed clearly ( Fig. 1j) (Portera-Cailliau et al. 2005) . Excellent labeling of axons enabled the reconstruction of complete axonal arbors in three dimensions from serial cortical sections (Fig. 1k) . Therefore, we successfully transfected neurons in the deep brain nucleus of postnatal animals. Moreover, we confirmed the applicability of our method to other brain regions, including the cerebral cortex and hippocampus (data not shown).
We examined the efficiency of two parameters of our electroporation, plasmid concentration and voltage amplitude. The efficiency of electroporation among various concentrations of plasmid DNA (0.2-2.0 lg/ll) was compared with the electric pulses of a fixed parameter (duration 50 ms; amplitude 100 V; 1 Hz for 5 s) using mice younger than P50 to examine the effect of plasmid concentration (Fig. 2a) . Transfection efficiency was calculated as the proportion of electroporation sites in which EGFPexpressing neurons were observed. Transfection efficiency in the LGN showed little difference between various concentrations of plasmid DNA (Fig. 2a) (0.2-0.5 lg/ll, 40.0 %, 2 in 5 sites; 0.8-1.0 lg/ll, 33.3 %, 1 in 3 sites; 2 lg/ll, 35.7 %, 5 in 14 sites, Chi-square test). It appeared that neurons transfected using higher plasmid DNA concentrations tended to exhibit higher intensities of EGFP expression despite the similarity in efficiency.
We next examined the effect of voltage amplitude on transfection efficiency with other parameters fixed as follows: plasmid concentration 2.0 lg/ll and electric pulses 50-ms duration at 1 Hz for 5 s (Fig. 2b) . The transfection efficiency in the LGN at 200 V was slightly higher than the lower voltage, but we did not find significant differences between the three different amplitudes (50 V, 40.0 %, 2 in 5 sites; 100 V, 35.7 %, 5 in 14 sites; and 200 V, 50.0 %, 5 in 10 sites, Chi-square test). We often found lesions around the electroporation site at 200 V, but the electroporations with 50 V or 100 V pulses are rarely induced lesions. Therefore, we used 50-ms square pulses at 1 Hz for 5 s at 100 V and a 2.0 lg/ll plasmid concentration in the following experiments.
Small numbers of EGFP-expressing neurons were usually observed at the sites of successful electroporation in the LGN (average 1.2 neurons/site). Plasmid concentration and electric pulse amplitudes did not influence the number of transfected neurons significantly. We found EGFP expression in neurons and glial cells. The transfection efficiency for glial cells was 35.7 %, which was comparable with neurons (35.7 %, 5 in 14 sites, conditions of electroporation: plasmid concentration of 2.0 lg/ll and electric pulses 100 V in amplitude and 50 ms in duration at 1 Hz for 5 s). EGFP-expressing neurons were sometimes observed in the region outside of the LGN (11 in 19 successful electroporation sites, 57.9 %, average: 0.89 neurons/site). They were mainly found in the region either facing the ventricle or around the glass pipette track in hippocampus, or occasionally in the nearby nuclei as ventral LGN. The transfection outside the target region should be mainly induced by the plasmid solution diffused out of the LGN, because we found the neurons labeled with fluorescent tracer in the same region when plasmid solution contains the fluorescent tracer. EGFP-expressing neurons were observed 3 days after electroporation. EGFP was expressed in soma and dendrites, but no labeled axons were observed in the cortex even after immunohistochemical staining. EGFP expression was maintained for a long time in living animals, and we found EGFP-expressing neurons in the animals 1 month after electroporation.
We tried electroporation using a nuclear permeabilizing agent, TCHD, to improve the expression of EGFP. TCHD may enhance the efficiency of electroporation in postmitotic neurons via the expansion of nuclear pores (De la Rossa et al. 2013) . Figure 3 shows the electroporation results using the plasmid solution containing TCHD. EGFP-expressing soma and dendrites were observed in the raw sections before immunostaining (Fig. 3a) . Clear EGFP labeling was observed in afferent axons in the visual cortex before immunostaining (Fig. 3c-left) . EGFP immunostaining significantly enhanced the EGFP signal (Fig. 3b , c-right), and most EGFP-labeled axons and dendrites were recognized in the unprocessed sections. Therefore, TCHD effectively improved EGFP expression. However, the efficiency was almost unchanged in the presence of TCHD (Fig. 2c) (addition of TCHD, 37.5 %, 3 in 8 sites, Chisquare test), and a few EGFP-expressing neurons (average, 2.0 neurons/site) were generally observed at the sites of successful electroporation. We also obtained successful EGFP expression in the LGN of cat (Fig. 4) . This result is the first demonstration of in vivo postnatal electroporation in the cat CNS. Electroporation was performed with TCHD at P38, and the survival period was 20 days. We targeted lamina A of the LGN by confirming visual responses to the contralateral eye. We found two EGFP-expressing cells in lamina A and geniculocortical axons in the visual cortex of unprocessed sections (Fig. 4a, b, d-f ). Labeled cortical axonal arbors were located primarily in layer IV in these same sections after immunostaining, and fine structures, such as axonal boutons and terminal swellings, were clearly observed (Fig. 4g, h ).
Discussion
This study established an electroporation method for the transfer of genes to a physiologically identified deep brain nucleus in postnatal mammals. This method requires only a conventional setup for extracellular recording, and it is not a highly demanding technique. We primarily targeted the LGN of the thalamus in the present study, but other regions or nuclei could be targeted.
Only a small number of cells were transfected at each site via the present method, which provided a detailed analysis of the morphology of individual neurons. Conventional electroporation using postnatal animals, in which the plasmid solution is administered into the ventricle, leads to the transfection of a large number of cells facing the ventricle (mouse: Boutin et al. 2008; rat: Kondoh et al. 2000; Molotkov et al. 2010 , ferret: Borrell 2010 . A previous study that combined a cortical injection of plasmid solution with electroporation using course electrodes beside the injection site showed a transfected region as large as 1 mm (Akaneya et al. 2005 ). The present method may transfect a small number of cells because the electric current flows through a small pipette tip and the current density is high enough to induce transfection only in a restricted area around the tip.
Although single-cell electroporation is reported in postnatal animals, it requires highly demanding techniques, such as patch-clamp recording or two-photon microscopy for in vivo imaging (Kitamura et al. 2008; Judkewitz et al. 2009 ) and can target neurons only in the brain surface. The single-cell juxtacellular recording-labeling technique enables targeting neurons in deep brain structures (Cohen et al. 2013; Oyama et al. 2013) . At the same time, however, it requires skillful technique to move the electrode tip accurately to the appropriate position in the close vicinity of cell membrane by monitoring spike waveforms and electrode resistance. The present technique using multiunit recording offers an easier and more convenient method for gene transfer to physiologically identified sites which is most suitable for the case that one wants to transfect neurons in the specified nuclei irrespective of cell types. In the present experiments, it took about an hour to complete the transfection surgery in an animal (2-4 sites for an animal). Such convenience is especially helpful in the population studies which make comparison among many animal groups.
We compared the transfection efficiency of electroporation of various plasmid concentrations and electric pulse amplitudes, and no significant differences between the parameters were observed. The transfection efficiency at the strongest amplitude (200 V) showed a slightly higher success rate, but a lesion was found at the electroporation site. Therefore, we did not test the effect of electroporation at higher amplitudes. Other parameters, such as the temporal pattern of electric pulses, might influence the transfection efficiency of electroporation (Haas et al. 2001; Akaneya et al. 2005) . Alternatively, the development of brain tissue might restrict the transfection efficiency in postnatal animals. Cell maturation may render the membrane less sensitive to electric pulses, or elaboration of the extracellular matrix might disturb the access of the plasmid solution to the cell membrane. We found successful electroporation in the mice as old as P47 but not in the mice elder than P60 (9 sites), which supports the latter possibility. Therefore, the present method is applicable to postnatal animals, but it may not be as effective in fully mature and aged animals.
While most of the electroporation techniques are used in in utero embryos or newborn animals, the present technique can be applicable to elder animals up to seven postnatal weeks. Electroporation technique which can be used on adolescent animals has a considerable merit, even if the technique is not suitable for elder or aged animals. Many maturational events of neural circuitry such as the critical period of sensory systems take place during the first several weeks after birth (Hensch 2004) . Because the present method can be used on animals at ages which encompass the maturation period, it can be an invaluable tool to elucidate postnatal maturation of neural circuitry. In addition, the usage of rather elder animals enables to identify target regions by monitoring characteristic neural activity such as sensory responses because neural circuitry is largely established in adolescence. In the present experiments, we could transfect neurons in lamina A of the LGN, which is the sublamina serving the contralateral eye, via the recording of visual responses in cats at developing ages. This functionally specific targeting cannot be achieved using previous methods, such as transgenic animals and conventional in utero electroporation.
We examined EGFP expression following a survival period of about 2 weeks in most animals, but previous reports demonstrated fluorescent protein expression 1 day after electroporation (Haas et al. 2001; Judkewitz et al. 2009 ). This difference is not because EGFP expression is slower in the present method. We observed EGFPexpressing soma and dendrites 3 days after electroporation. However, we could not detect EGFP signals in cortical axonal arbors 3 days after electroporation. The delayed fluorescent expression in axons may reflect the period required for transportation of the protein from soma to distant axons. Modification of plasmid DNA, such as the insertion of an axon-targeting signal, might improve the rate and intensity of EGFP expression in axons (Furuta et al. 2001 ).
The present method of electroporation is applicable to rodents and cats. Therefore, this method would be useful for the study of the fine morphology of neurons in the deep brain nuclei in various species, including rodents, carnivores and possibly primates. Furthermore, it can be used to explore the molecular machinery of neural morphology via the manipulation of the expression of functional molecules. The present technique also suggests an application which combines local injection and electroporation. In the present experiments, we injected plasmid solution containing an anterograde neural tracer, mini-Ruby to aid in finding the location of injection and axonal projection. Usage of retrograde tracer might be useful for the analysis of reciprocal connection. Injection of plasmid solution containing pharmacological agents or viral vectors would also be attractive applications because it allows to examine the effect of pharmacological or genetic manipulation on the electroporated cells. Therefore, the novel in vivo electroporation method in the present study can contribute greatly to the elucidation of the function of neural circuitry in the CNS of mammals.
